Podocyte p53 Limits the Severity of Experimental Alport Syndrome.
about
Autophagy is involved in mouse kidney development and podocyte differentiation regulated by Notch signalling.p53 induces miR199a-3p to suppress SOCS7 for STAT3 activation and renal fibrosis in UUO.Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome.Bromide supplementation exacerbated the renal dysfunction, injury and fibrosis in a mouse model of Alport syndrome.Endothelin A receptor activation on mesangial cells initiates Alport glomerular disease.Pathogenicity of a Human Laminin β2 Mutation Revealed in Models of Alport Syndrome.STAT3 inhibition attenuates the progressive phenotypes of Alport syndrome mouse model.Long-term treatment with EGFR inhibitor erlotinib attenuates renal inflammatory cytokines but not nephropathy in Alport syndrome mouse model.Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis
P2860
Q33844686-57FD36F1-9B69-4D2F-8AA1-E2DBE596D6D9Q37668124-BE64BD72-C178-4A4F-ABA6-2BEAC4503B0CQ38941236-C203422D-787E-4E25-84B3-C7D39B2E30C8Q41618166-D3A6E8CE-D7DF-4C6A-8471-FD35A7C6AE6EQ42054644-C856CA7E-0A11-408E-8AA4-DBC8501E195BQ47273807-6692940D-D507-44FD-AC30-F12087DD7019Q47587148-88D284F9-462A-4939-8480-B45B9E7F5644Q51147438-55071C44-12C8-465C-935F-74D90304EFF9Q58129865-728C90A4-39C6-4DBB-9460-1BBB20CBF76E
P2860
Podocyte p53 Limits the Severity of Experimental Alport Syndrome.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Podocyte p53 Limits the Severity of Experimental Alport Syndrome.
@ast
Podocyte p53 Limits the Severity of Experimental Alport Syndrome.
@en
type
label
Podocyte p53 Limits the Severity of Experimental Alport Syndrome.
@ast
Podocyte p53 Limits the Severity of Experimental Alport Syndrome.
@en
prefLabel
Podocyte p53 Limits the Severity of Experimental Alport Syndrome.
@ast
Podocyte p53 Limits the Severity of Experimental Alport Syndrome.
@en
P2093
P2860
P356
P1476
Podocyte p53 Limits the Severity of Experimental Alport Syndrome
@en
P2093
Hirofumi Kai
Keishi Motomura
Kohei Omachi
Kosuke Koyama
Manabu Taura
Ryosuke Fukuda
Tomoaki Koga
Tsubasa Yokota
Tsuyoshi Shuto
Yoshihiro Komohara
P2860
P304
P356
10.1681/ASN.2014111109
P577
2015-05-12T00:00:00Z